Benefits Effective Weight Loss: Clinical trials have demonstrated that GLP-1 agonists can lead to significant weight loss, especially in individuals with obesity or overweight conditions
Regular Monitoring Regular follow-ups allow us to assess your progress
AOD-9604 is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications
Semaglutide GLP-1 for weight loss is administered through a once-weekly subcutaneous injection
Reported side effects include water retention, flushing, headache, tingling in the extremities, elevated IGF-1 levels, impaired glucose tolerance, and injection site reactions including pain and infection risk